Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination

Surgical Oncology Clinics of North America
John F ThompsonRoger F Uren

Abstract

Surgical strategies for managing patients who have primary cutaneous melanoma have changed dramatically over the past 30 years. More conservative excision margins have been shown to be adequate, and routine complete lymph node dissection (CLND)has been abandoned since the sentinel node (SN) biopsy technique was introduced. Knowledge of a patient's SN status not only provides a reliable guide to prognosis, but also allows CLND to be avoided in 80% to 85% of patients. Recent clinical trial results suggest that SN biopsy, with immediate CLND if an SN is positive,confers a survival advantage in those who have metastatic disease in regional nodes. Minimally invasive and noninvasive methods of SN assessment, such as magnetic resonance spectroscopy, are being evaluated.

References

Sep 9, 1992·JAMA : the Journal of the American Medical Association
Apr 1, 1992·Archives of Surgery·D L MortonA J Cochran
Apr 1, 1991·Archives of Surgery·U Veronesi, N Cascinelli
Jun 1, 1985·The Australian and New Zealand Journal of Surgery·G W MiltonW H McCarthy
Jan 1, 1966·The Journal of Urology·E SayeghF Busch
Dec 1, 1994·Melanoma Research·R F UrenW H McCarthy
Dec 1, 1994·Annals of Surgery·D ReintgenG Lyman
Oct 1, 1993·Surgical Oncology·J C AlexD N Krag
Mar 28, 1998·Archives of Surgery·P R KelemenA E Giuliano
Jun 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J E GershenwaldM I Ross
Oct 6, 1998·Hematology/oncology Clinics of North America·W H McCarthy, H M Shaw
Jan 27, 1999·The Journal of Thoracic and Cardiovascular Surgery·A G LittleK D Murray
Aug 7, 1999·Journal of the American College of Surgeons·J F ThompsonR B Howman-Giles
Apr 12, 2000·The British Journal of Surgery·L JansenB B Kroon
Jun 30, 2000·BMJ : British Medical Journal·J M Thomas, E J Patocskai
Jan 5, 2001·The Surgical Clinics of North America·Y KitagawaM Kitajima
Mar 10, 2001·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M R KeshtgarP J Ell
Oct 3, 2002·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M H E DotingH Schraffordt Koops
Dec 5, 2002·Annals of Surgical Oncology·Jaime M RanieriJohn J Coleman
Apr 4, 2003·Cancer·David KhayatUNKNOWN French Group of Research on Malignant Melanoma
Jun 6, 2003·The Journal of Investigative Dermatology·David A Barzilai, Mendel E Singer
Jun 10, 2003·Annals of Surgical Oncology·Grant W CarlsonCynthia Cohen
Jul 4, 2003·Annals of Surgical Oncology·Susanne H EstourgieBin B R Kroon
Jul 30, 2003·American Journal of Surgery·George I Salti, Tapas K Das Gupta
Sep 10, 2003·The American Journal of Surgical Pathology·David B Troxel
Feb 20, 2004·The New England Journal of Medicine·J Meirion ThomasUNKNOWN Scottish Cancer Therapy Network
Apr 21, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Alistair J CochranDonald L Morton
Jun 11, 2004·Seminars in Oncology·Roger F UrenJohn F Thompson
Jul 17, 2004·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·J M Thomas, M A Clark
Jul 20, 2004·BMJ : British Medical Journal·J Meirion Thomas, Matthew A Clark
Aug 18, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D J DewarM G Cook
Aug 26, 2004·The British Journal of Dermatology·D L Morton, A J Cochran

❮ Previous
Next ❯

Citations

Jul 1, 2008·Biomedical Imaging and Intervention Journal·Es KohMb Barton
Feb 2, 2008·Annals of Surgical Oncology·Jennifer L EricksonTina J Hieken
Oct 18, 2011·Surgery·Christina Tragos, Tina J Hieken
Jul 22, 2008·Surgical Oncology·Richard A ScolyerJohn F Thompson
Dec 18, 2007·Seminars in Oncology·Mark B Faries, Donald L Morton
Jan 18, 2015·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·R L ReadA J Spillane
Mar 25, 2015·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·N MozzilloC Caracò
Mar 15, 2015·Surgical Oncology Clinics of North America·Jeffrey M FarmaCary Hsu
Aug 28, 2013·Surgery·Philip M SpanheimerRonald J Weigel
Nov 26, 2010·Annals of Surgery·Andrea MaurichiMario Santinami
Feb 6, 2007·American Journal of Clinical Pathology·Rajmohan MuraliRichard A Scolyer
Nov 23, 2016·Irish Journal of Medical Science·R SehgalG T O'Donoghue
Feb 28, 2008·Current Opinion in Oncology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.